Matching cancer treatment to patients

Israeli biotech Nucleai (reported here previously) has progressed from merely analyzing biopsies. It now uses its computer vision and machine learning to study the characteristics of tumors, helping predict which cancer patients will respond to which immunotherapy medication.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *